Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,263	1,147	801.15	744.88	740.38	510.39
Other Revenue	16.26	11.79	1.39	-	-	-
Revenue	1,279	1,159	802.54	744.88	740.38	510.39
Revenue Growth (YoY)	40.38%	44.38%	7.74%	0.61%	45.06%	27.49%
Cost of Revenue	1,026	970.28	703.5	657.43	640.13	430.13
Gross Profit	253.48	188.44	99.04	87.45	100.24	80.26
Selling, General & Admin	132.21	123.95	64.3	50.88	56.03	51.83
Other Operating Expenses	61.49	14.04	7.06	6.8	11.57	11.77
Operating Expenses	205.09	148.92	80.1	67.73	78.7	69.37
Operating Income	48.39	39.52	18.94	19.72	21.54	10.89
Interest Expense	-0.48	-	-	-	-	-
Interest & Investment Income	8.88	8.88	5.06	2.05	0.01	0
Other Non Operating Income (Expenses)	-3.34	-3.34	-5.29	-4.77	-5.4	-5.84
EBT Excluding Unusual Items	53.45	45.05	18.7	16.99	16.15	5.05
Other Unusual Items	-1.76	-1.76	-1.95	-1.23	-1.54	-0.01
Pretax Income	51.69	43.29	29.96	15.77	14.61	5.04
Income Tax Expense	11.67	9.57	8.35	4.52	4.12	1.31
Net Income	40.02	33.72	21.61	11.25	10.49	3.73
Net Income to Common	40.02	33.72	21.61	11.25	10.49	3.73
Net Income Growth	51.95%	56.02%	92.16%	7.24%	181.14%	7.57%
Shares Outstanding (Basic)	50	172	88	60	51	50
Shares Outstanding (Diluted)	50	172	88	60	51	50
Shares Change (YoY)	-67.93%	96.59%	46.51%	18.35%	1.00%	6.46%
EPS (Basic)	0.80	0.20	0.25	0.19	0.21	0.07
EPS (Diluted)	0.71	0.20	0.25	0.19	0.21	0.07
EPS Growth	317.48%	-20.64%	31.16%	-9.39%	180.50%	0.27%
Free Cash Flow	56.17	-197.69	173.09	-69.39	15.6	-23.71
Free Cash Flow Per Share	1.12	-1.15	1.98	-1.16	0.31	-0.47
Gross Margin	19.81%	16.26%	12.34%	11.74%	13.54%	15.73%
Operating Margin	3.78%	3.41%	2.36%	2.65%	2.91%	2.13%
Profit Margin	3.13%	2.91%	2.69%	1.51%	1.42%	0.73%
Free Cash Flow Margin	4.39%	-17.06%	21.57%	-9.32%	2.11%	-4.65%
EBITDA	62.01	50.45	27.68	29.77	31.24	15.26
EBITDA Margin	4.85%	4.35%	3.45%	4.00%	4.22%	2.99%
D&A For EBITDA	13.62	10.94	8.74	10.05	9.7	4.37
EBIT	48.39	39.52	18.94	19.72	21.54	10.89
EBIT Margin	3.78%	3.41%	2.36%	2.65%	2.91%	2.13%
Effective Tax Rate	22.58%	22.11%	27.87%	28.68%	28.22%	26.02%
Revenue as Reported	1,288	1,168	823.08	747.82	740.76	510.56
Advertising Expenses	-	0.76	0.36	0.19	0.35	0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.